Related Experiment Video
Updated: Feb 3, 2026

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Autophagy Modulators and Neuroinflammation.
Kyoung Sang Cho1, Jang Ho Lee2, Jeiwon Cho2,3
1Department of Biological Sciences, Konkuk University, Seoul, Korea.
Autophagy modulators show promise for treating neurological disorders by reducing neuroinflammation. Activating autophagy may offer neuroprotection and combat neurodegenerative diseases linked to inflammation.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Neuroinflammation is central to neurological disorder development.
- Autophagy's role in regulating neuroinflammation is a growing research area.
- Impaired autophagy is implicated in neurodegenerative disease pathogenesis.
Purpose of the Study:
- To review research on autophagy's role in controlling neuroinflammation.
- To evaluate autophagic modulators in mammalian cells and animal models.
- To assess the potential of autophagy modulation for neurological disorders.
Main Methods:
- Review of recent studies on autophagy and neuroinflammation.
- Focus on studies reporting anti-neuroinflammatory effects.
- Inclusion of studies showing autophagy modulators activating neuroinflammation.
Main Results:
- Autophagic modulators exhibit both neuroprotective and anti-neuroinflammatory effects.
- Mechanisms of action and therapeutic limitations are discussed.
- Evidence suggests autophagy modulation impacts neuroinflammation.
Conclusions:
- Autophagy activators are promising for treating neuroinflammatory neurological disorders.
- Targeting autophagy offers a potential therapeutic strategy.
- Further research is needed to explore limitations and optimize treatments.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Internal Receptors
Cooperative Allosteric Transitions
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...

